We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
We are seeking your views on proposals to enable all community pharmacies to access ‘hub and spoke’ dispensing.
First published during the 2019 to 2022 Johnson Conservative government
The UK's second 5-year national action plan setting out ambitions and actions for the next 5 years in support of the 20-year vision for antimicrobial resistance (AMR).
First published during the 2022 to 2024 Sunak Conservative government
Implementing the Artificial Intelligence (AI) White Paper principles.
We are seeking views about making amendments to references to Public Health England and the Regional Health and Social Care Board within the Human Medicines Regulations 2012.
The government’s plan to support a thriving UK medtech sector and make sure the health and care system can reliably access safe, effective and innovative medical technologies to deliver the best outcomes for patients.
Achievements made since the launch of the medtech strategy and the next steps to boost the adoption of medical technology in the NHS.
This consultation will inform the government’s proposal to enable pharmacy technicians to supply and administer medicines using patient group directions.
Government’s response to the independent review into racial, ethnic and other factors leading to unfair biases in the design and use of medical devices.
We are seeking your views on the design, development, evaluation and use of medical devices.
The government’s response to the Science, Innovation and Technology Committee’s report into the antimicrobial potential of bacteriophages.
Report on all regulations in force during the first reporting period made using the powers in specific sections of the act, including stakeholder feedback and the department’s response.
The Medicines and Healthcare Products Regulatory Agency (MHRA) have launched a public consultation to propose reclassification of Codeine Linctus to prescription-only medicine.
This consultation collected views on expanding the use of naloxone. It ran for 8 weeks and was open to all interested individuals and organisations.
This is a consultation on a statutory instrument to amend the Human Medicines Regulations 2012 to remove the provision which provides the legal basis to the European Commission Decision Reliance Procedure (ECDRP).
An agreement between DHSC, NHS England and ABPI to support patient access to medicines, the financial sustainability of the NHS and the UK life sciences sector.
The MHRA is reviewing its approach to engagement with healthcare professionals to improve the safety of medicines and medical devices.
The full government response to the Lord O'Shaughnessy independent review of UK commercial clinical trials.
This consultation considers the proposed review of the statutory scheme to control the cost of branded health service medicines.
The outline terms agreed between DHSC and the Association of the British Pharmaceutical Industry (ABPI) for the voluntary scheme.
First published during the 2016 to 2019 May Conservative government
The key terms of the agreement reached between the Department of Health and Social Care, NHS England and the Association of the British Pharmaceutical Industry for a new voluntary scheme.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).